Compound ID | 647

Update compound information

LCB01-0062

Class: Oxazolidinone

Spectrum of activity: Gram-negative
Details of activity: Potent in vitro activity against VRE, MRSA and PRSP; there has not been any news since 2007. The program to identify oxazolidinones potent against drug resistant pathogens is ongoing according to their company website
Description: Jung S, Yun I, Park H, Kim Y, Woo S, Cho Y, et al. In vitro activity of LCB01-0062, a novel oxazolidinone against gram-positive cocci. 47th-ICAAC-2007 2007;248
Institute where first reported: LegoChem Biosciences
Year first mentioned: 2007
Highest developmental phase: Preclinical
Development status: Inactive
Chemical structure(s):
Click here for structure editor
Molecular weight: 403.41
Iso. SMILES: N=C(NO)C1=CC=C(C2=CC=C(N3C[C@H](CNC(C)=C)OC3=O)C=C2F)C=N1.O
InChI Key: NJCJAULEWWRLEG-UQKRIMTDSA-N
Can. SMILES: C=C(C)NC[C@H]1CN(C2=CC(=C(C=C2)C3=CC=C(C(=N)NO)N=C3)F)C(=O)O1.O
InChI: InChI=1S/C19H20FN5O3.H2O/c1-11(2)22-9-14-10-25(19(26)28-14)13-4-5-15(16(20)7-13)12-3-6-17(23-8-12)18(21)24-27;/h3-8,14,22,27H,1,9-10H2,2H3,(H2,21,24);1H2/t14-;/m0./s1
External links:
Citation: https://www.sciencedirect.com/science/article/pii/S0924857912003226?via%3Dihub

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.